Table 5.
Characteristics of patients according to CRVE quartile
| Characteristic | Quartile 1 (145.0 to 189.4) (n = 63) | Quartile 2 (189.5 to 209.7) (n = 63) | Quartile 3 (209.8 to 229.3) (n = 63) | Quartile 4 (229.5 to 298.4) (n = 63) | Odds Ratio | 95% Confidence Interval | P |
|---|---|---|---|---|---|---|---|
| Age (median, range) | 62 (20 to 83) | 61 (20 to 84) | 62 (35 to 84) | 60 (29 to 81) | 0.36 | ||
| Gender (male, %) | 41 (65.1%) | 35 (55.6%) | 43 (68.3%) | 45 (71.4%) | 0.75 | 0.35 to 1.58 | 1.00 |
| eGFR (mean, SD, ml/min per 1.73 m2) | 37.3 (25.5) | 51 (33.6) | 67.7 (26.0) | 60.8 (30.8) | 0.01 | ||
| CKD 3 to 5 | 48 (76.2%) | 34 (54.0%) | 16 (25.4%) | 28 (44.4%) | 4.00 | 1.86 to 8.58 | 0.01 |
| Hypertension | 45 (71.4%) | 42 (66.7%) | 33 (52.4%) | 37 (58.7%) | 1.76 | 0.84 to 3.69 | 0.19 |
| Number of antihypertensives (mean, SD) | 2 (1.5) | 1.7 (1.5) | 0.94 (1.4) | 0.94 (1.3) | 0.04 | ||
| Diabetes | 18 (28.6%) | 16 (25.4%) | 17 (27%) | 24 (38.1%) | 0. 65 | 0.31 to 1.37 | 0.35 |
| Dyslipidemia | 36/61 (59%) | 31/62 (50%) | 36/61 (59%) | 35/62 (56.5%) | 1.11 | 0.54 to 2.27 | 0.86 |
| Smoking history | 36 (57.1%) | 38 (60.3%) | 38 (60.3%) | 39 (61.9%) | 0.82 | 0.40 to 1.67 | 0.72 |
The P values, odds ratios, and 95% Confidence intervals were compared between individuals in quartiles 1 and 4. CRVE, central retinal vein equivalent; eGFR, estimated GFR; CKD, chronic kidney disease.